Saphris and Fanapt: Two New Antipsychotics
The Carlat Psychiatry Report, Volume 7, Number 12, December 2009
https://www.thecarlatreport.com/newsletter-issue/tcprv7n12/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics
Heidi W. Ashih, MD, PhD
You’ve probably heard about Fanapt (iloperidone) and Saphris (asenapine), two antipsychotics that have recently won FDA approval for the acute treatment of schizophrenia, and, in the case of Saphris, for the treatment of manic and mixed episodes of bipolar disorder. Are these more “me too”…
You can't view details of this content, please login or buy subscription here
Heidi W. Ashih, MD
Psychiatry Resident, Cambridge Health Alliance, Clinical Fellow in Psychiatry, Harvard Medical School
Dr. Ashih reports no financial relationships with any commercial companies related to this article